MissionIR Articles

DS Healthcare Group, Inc. develops and markets hair, skin, health and personal care products. The company’s products include the Revita shampoo and Revita.Cor conditioner for hair growth stimulation; Spectral.DNC spray formula, Spectral.DNC-L lotion, and Spectral…

Synergy Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing drugs for treating gastrointestinal (GI) disorders and diseases. Synergy’s lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist which has completed Phase…

Prima BioMed Ltd. is a biotechnology company researching and developing licensed medical biotechnology products in Australia. The company’s lead product is CVac, a cancer vaccine for patients in remission, which has completed two human clinical…

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company focusing on the discovery, acquisition, development and commercialization of proprietary therapeutics that target cancer stem cells (CSCs) and tumor bulk. In addition to developing StemScreen platform technology…

Rosetta Genomics Ltd. develops diagnostic tools for microRNAs, a group of genes produced using instructions encoded in DNA. The company offers diagnostic tests, including miRview mets2, a microRNA-based diagnostic used to identify 42 tumor types…

AtheroNova Inc. is a development stage company engaging in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. The company develops intellectual property that uses certain pharmacological compounds for the…

Opexa Therapeutics, Inc. is a biopharmaceutical company that develops personalized cellular therapies to treat multiple sclerosis (MS) using its proprietary T-cell technology. Its leading therapy candidate includes Tcelna, a novel T-cell immunotherapy, which is in…

OHR Pharmaceutical, Inc. is a biotechnology company. The company’s products include Squalamine, an anti-angiogenic small molecule with a novel intracellular mechanism that inhibits vascular endothelial, platelet derived and basic fibroblast growth factors to treat the…

PharmAthene, Inc. is a biodefense company developing medical countermeasures against biological and chemical threats. The company’s product candidates include: SparVax, an anthrax vaccine which has completed a Phase II clinical trial for post-exposure prophylaxis; Valortim,…

Mast Therapeutics, Inc. (NYSE: MSTX) is a biopharmaceutical company developing therapies for life-threatening diseases. The company’s lead product candidate is MST-188, which has hemorheologic, cytoprotective, and anti-inflammatory properties and is in phase 3 study for…

Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company developing prescription drugs targeting rare neuromuscular and neurological diseases and disorders. The company’s principal product is Firdapse, which is in Phase III clinical trial for the…

Targeted Medical Pharma, Inc. is a biotechnology company that develops and distributes prescription medical foods for chronic disease treatment, convenience kits, and generic pharmaceuticals to physicians and pharmacies in the United States and Middle East.…

PhotoMedex, Inc. is a skin health company that provides integrated disease management and aesthetic solutions to dermatologists, professional aestheticians, and consumers. The company offers products and services that address skin diseases and conditions, including psoriasis…

Regado Biosciences, Inc. is a biopharmaceutical company discovering and developing antithrombotic drug systems for acute and sub-acute cardiovascular and other indications. The company’s lead product includes REG1, an anticoagulant in clinical trials for use in…

Can-Fite BioPharma, Ltd. is a biotechnology company developing drugs for treating cancer and autoimmune inflammatory diseases. Principally, the company develops CF101, which is in Phase III study for the treatment of psoriasis and has completed…

Enzo Biochem, Inc. is an integrated life sciences and biotechnology company that focuses on diagnostic and research products. The company operates in three segments: the Clinical Labs segment offers clinical laboratory tests/procedures used in general…

Atossa Genetics, Inc. is a healthcare company developing and marketing cellular and molecular diagnostic risk assessment products for breast cancer. The company’s diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about…